Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
J Leukoc Biol. 2011 Aug;90(2):285-91. doi: 10.1189/jlb.0211087. Epub 2011 May 17.
Enhanced eosinophil trafficking from bone marrow to the tissue is a hallmark of allergic diseases. We have shown previously that PGI(2) markedly attenuates the locomotion of human eosinophils in vitro. Here, we set out to determine the effect of PGI(2) on the trafficking of bone marrow eosinophils in the guinea pig. Shape change of bone marrow eosinophils was determined by flow cytometry, and chemotaxis assays were performed using a transwell migration system. Eosinophil release from bone marrow of guinea pigs was investigated in the isolated, perfused hind-limb preparation. We found that PGI(2) prevented the mobilization of eosinophils from bone marrow and attenuated the shape change and chemotactic responses of bone marrow eosinophils. These effects were mimicked by iloprost and were prevented by the IP antagonist CAY10441 and the adenylyl cyclase inhibitor SQ22536. Immunohistochemical staining of bone marrow confirmed the expression of IPs by bone marrow eosinophils. The rate-limiting enzyme of PGI(2) formation, PGIS, was found in large mononuclear cells. These data show that IP activation negatively modulates the mobilization and locomotion of bone marrow eosinophils and might therefore also protect against exaggerated recruitment of eosinophils to inflammatory sites.
从骨髓向组织中迁移的嗜酸性粒细胞增强是过敏疾病的一个标志。我们之前已经表明,PGI(2)显著减弱了人嗜酸性粒细胞在体外的迁移。在这里,我们着手确定 PGI(2)对豚鼠骨髓嗜酸性粒细胞迁移的影响。通过流式细胞术测定骨髓嗜酸性粒细胞的形态变化,并使用 Transwell 迁移系统进行趋化性测定。在分离的、灌注的后肢制备物中研究了豚鼠骨髓中嗜酸性粒细胞的释放。我们发现,PGI(2)可防止嗜酸性粒细胞从骨髓中动员,并减弱骨髓嗜酸性粒细胞的形态变化和趋化反应。这些作用可被 iloprost 模拟,并可被 IP 拮抗剂 CAY10441 和腺苷酸环化酶抑制剂 SQ22536 所阻止。骨髓的免疫组织化学染色证实了 IPs 在骨髓嗜酸性粒细胞中的表达。PGI(2)形成的限速酶,PGIS,存在于大单核细胞中。这些数据表明,IP 激活可负向调节骨髓嗜酸性粒细胞的动员和迁移,因此也可能防止嗜酸性粒细胞过度募集到炎症部位。